Literature DB >> 19896762

Bilateral diffuse intracerebral hemorrhagic infarction after cranioplasty with autologous bone graft.

Ki Seong Eom1, Dae Won Kim, Sung Don Kang.   

Abstract

We present the first case of a bilateral diffuse intracerebral hemorrhagic infarction following cranioplasty using an autologous bone graft. The case is that of a 63-year-old man who had undergone previous decompressive craniectomy due to right middle cerebral artery and posterior cerebral artery territory infarction. In order to avoid this extremely rare complication, the possible pathogenic mechanism underlying the deleterious cascade following cranioplasty is discussed. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19896762     DOI: 10.1016/j.clineuro.2009.10.010

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Efficacy and Versatility of the 3-D Titanium Mesh Implant in the Closure of Large Post-Craniectomy Osseous Defects, and its Therapeutic Role in Reversing the Syndrome of the Trephined: Clinical Study of a Case Series and Review of Literature.

Authors:  Priya Jeyaraj
Journal:  J Maxillofac Oral Surg       Date:  2015-05-26

2.  Sudden Death Following Cranioplasty.

Authors:  Stephen Honeybul
Journal:  J Korean Neurosurg Soc       Date:  2016-02-29

3.  Intracerebral Hemorrhagic Infarction after Cranioplasty in a Patient with Sinking Skin Flap Syndrome.

Authors:  Jai-Hyuck Han; Mou-Seop Lee
Journal:  Korean J Neurotrauma       Date:  2016-10-31

4.  Unexpected complications immediately after cranioplasty.

Authors:  Akihito Kato; Hiroyuki Morishima; Goro Nagashima
Journal:  Acute Med Surg       Date:  2017-02-22

Review 5.  Acute supratentorial ischemic stroke: when surgery is mandatory.

Authors:  Gabriele Ronchetti; Pier Paolo Panciani; Roberto Stefini; Giannantonio Spena; Marco Maria Fontanella
Journal:  Biomed Res Int       Date:  2014-01-14       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.